Dr. Hatem Ali, MD

Dr. Ali practices at Mission Surgical Group in Riverside, California.

Dr. Ali's NPI, 1821259466, was assigned on June 17, 2008. Dr. Ali graduated from Cairo University School of Medicine in 2001. Dr. Ali holds California license A108629.

Dr. Ali's primary practice is Mission Surgical Group, at 3660 Park Sierra Dr, Riverside, CA 92505 in Riverside County. The practice phone is (951) 278-8870.

Dr. Ali's primary practice is Mission Surgical Group in Riverside, California. Dr. Ali is also affiliated with Riverside University Health System - Medical Center. The medical group on file is Nephrology Associates Medical Group. Dmand AI also links Dr. Ali to 4 more hospitals, 2 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ali practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Ali's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Ali is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Ali's licenses on file in 3 states: California, Illinois and New Mexico.

Dmand AI lists chronic anemia, chronic kidney disease, gout and parathyroid gland disorder among the conditions Dr. Ali treats.

CMS data shows 1,477 Medicare services from Dr. Ali across 9 procedure codes in 2024, for 347 Medicare patients. Medicare paid $167,827 for them.

CMS counts 347 Medicare patients who saw Dr. Ali in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 65% are also on Medicaid. Their average risk score is 5.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ali's median patient age at 67, with 46% women.

In 2024, Dr. Ali wrote 2,128 Medicare Part D claims for 264 patients. 75% of them were for generic drugs. CMS names the drug for 1,883 of them, across 43 drugs with 11 or more claims each, at $463,051 in total drug cost. In 2023, CMS named 1,784 claims across 42 drugs.

Dr. Ali accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 40 papers to Dr. Ali, published from 2009 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Kidney Transplantation, Graft Survival and Graft Rejection. Dr. Ali has published most often in Ren Fail. Dr. Ali's most frequent co-authors are Karim Soliman, Mahmoud Mohamed, MD and Wisit Cheungpasitporn, MD.

CMS Open Payments shows 275 general payments to Dr. Ali from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,792.

Dr. Ali graduated from Cairo University School of Medicine in 2001.

Dr. Ali is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.